The fact
The deal would value the company at 23 billion in market capitalization.
Shareholders expect a bidding war in the biotech sector.
Click the link to read an article on the topic:
Discover
The deal would value the company at 23 billion in market capitalization.
Shareholders expect a bidding war in the biotech sector.